Work

Final Results from the Phase 2 Revive Study Investigating the Hepcidin Mimetic Rusfertide in Patients with Polycythemia Vera (PV)

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-197985

Authors: Aaron T. Gerds, Andrew T. Kuykendall, Marina Kremyanskaya, Ellen K. Ritchie, Jason Gotlib, Jeanne Palmer, Kristen M. Pettit, Victor Priego, Uttam Kumar Nath, Abdulraheem Yacoub, Arkapal Bandyopadhyay, Suneel Gupta, Sarita Khanna, Arturo Molina, Naveen Pemmaraju

Institutions: Cleveland Clinic, Moffitt Cancer Center, Icahn School of Medicine at Mount Sinai, NewYork–Presbyterian Hospital, Weill Cornell Medicine, Weill Cornell Medical Center, Stanford Medicine, Stanford Cancer Institute, Stanford University, Mayo Clinic Hospital, University of Michigan, Michigan Medicine, Center for Cancers and Blood Disorders, All India Institute of Medical Sciences Rishikesh, University of Kansas Medical Center, All India Institute of Medical Sciences, Kalyani, Protagonist Therapeutics (United States), The University of Texas MD Anderson Cancer Center

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405038929

Cites:

Cited by: 5

Related to: 10